27
Participants
Start Date
June 1, 2021
Primary Completion Date
November 30, 2021
Study Completion Date
December 31, 2021
Heparin sodium
Nebulized inhalation of 5 mL of a solution containing high molecular weight heparin - enriched heparin - 2.5mg/mL and 0.9% saline solution, every 4 hours for 7 days, except during the nighttime (5 doses/day)
Placebo
Nebulized inhalation of 5 mL of 0.9% saline solution, every 4 hours for 7 days, except during the nighttime (5 doses/day)
School of Medicine at Botucatu- Paulista State University- UNESP, São Paulo, Brazil, Botucatu
Hospital das Clinicas de Boucatu, Botucatu
UPECLIN HC FM Botucatu Unesp
OTHER